Ziresovir reduces respiratory syncytial virus (RSV) symptoms and viral load in infants, offering hope for an effective ...
China: In a promising development for pediatric care, a recent study has highlighted the efficacy of Ziresovir in treating ...
For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and ...
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a clinical stage biopharmaceutical company focused on the development of ...
Current strategies to prevent severe RSV disease in infants include maternal vaccination with the RSV prefusion F vaccine ...
Dr. Lei Qian, Vice President of Clinical Development of Innovent, stated, "We are delighted that the results of the Phase 3 study DREAMS-2 for mazdutide in T2D will be presented in the form of a ...